For example, intracerebroventricular injection of soluble Aβ42 oligomers decreased phosphorylation of CREB and reduced mRNA levels of its target gene, BDNF (discussed below), consistent with data in human AD. The gene discussed is CREB1; the disease is Alzheimer disease.